Trump’s 200% tariff threat leaves pharma firms scrambling with scenario planning by CNBC Markets | July 11, 2025 12:10 pm | US Markets A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn.
